Selskabets formål er fabrikation, handel, financiering og hermed beslægtet virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 5.9 mio. | 14 t. | 2 mio. | 1.1 mio. | 1 | |
CVR: 52893119
Secondary names: CALPLCOMPAGNIET ApS
Companies in the same industry and area
CVR 34668272
CVR 45984842
CVR 44714922
CVR 45663205
CVR 37033308
Compared to 131 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
The financial health of GUNNAR KJEMS ApS appears stable, with a slight increase in revenue from 5,805,802 DKK in 2023 to 5,917,792 DKK in 2024, although profit has decreased from 28,934 DKK to 13,584 DKK during the same period. Over the past five years, revenue has shown a generally stable trend, peaking at 6,229,912 DKK in 2022, while profit margins have fluctuated significantly, indicating potential concerns regarding operational efficiency. The company's equity has gradually increased, reaching 1,059,447 DKK in 2024, which reflects a strengthening financial position. However, the declining profit and relatively low margins suggest that GUNNAR KJEMS ApS may face challenges in maintaining profitability within the competitive pharmaceutical manufacturing industry.
AI-generated summary
companydata.dk